Page last updated: 2024-08-24

valsartan and Acute Lung Injury

valsartan has been researched along with Acute Lung Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, W; Gong, J; Guo, Q; Huang, W; Li, J; Li, X; Li, Y; Lin, Y; Lou, A; Meng, Y; Qiu, H; Sun, J; Wang, G; Wang, J; Xu, Q	1

Other Studies

1 other study(ies) available for valsartan and Acute Lung Injury

Article	Year
Sacubitril/valsartan alleviates sepsis-induced acute lung injury via inhibiting GSDMD-dependent macrophage pyroptosis in mice. The FEBS journal, 2023, Volume: 290, Issue:8 Topics: Acute Lung Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Inflammasomes; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Sepsis; Valsartan	2023

Article

Year

Sacubitril/valsartan alleviates sepsis-induced acute lung injury via inhibiting GSDMD-dependent macrophage pyroptosis in mice.

The FEBS journal, 2023, Volume: 290, Issue:8

Topics: Acute Lung Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Inflammasomes; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Sepsis; Valsartan

2023